Cyclic pharyngeal lymphoiditis: immunological considerations.
This communication presents the concept that recurrent infections of the lingual tonsils, lateral pharyngeal lymphoid bands and lymphoid follicles on the posterior pharyngeal wall, occurring with the same periodicity, is a cyclic clinical and immunological entity. These patients lacked resistance to the normal flora of the nasopharynx and pharynx. They were accordingly treated with a mixed respiratory bacterial vaccine, administered intradermally and according to a formulated program, to improve resistance or immunity of the lymphoid tissue. These patients showed definite improvement by this method of therapy. It is suggested that the effectiveness of therapy was accomplished through the immunological process of cell-mediated immunity. The immunobiologic development of cell-mediated immunity by T thymic-dependent cells and humoral immunity by B cells is briefly discussed.
D000818:Animals; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007711:Klebsiella pneumoniae / Q000276:immunology; D008205:Lymphangitis / Q000276:immunology* / Q000517:prevention & control; D051379:Mice; D009343:Neisseria / Q000276:immunology; D010614:Pharynx; D051381:Rats; D012008:Recurrence; D013210:Staphylococcus / Q000276:immunology; D013291:Streptococcus / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology; D014069:Tonsillitis / Q000276:immunology* / Q000517:prevention & control
D001428:Bacterial Vaccines